These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25212506)

  • 1. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
    Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
    BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
    Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
    BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
    Ohara Y; Oda T; Sugano M; Hashimoto S; Enomoto T; Yamada K; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Morishita Y; Ohkohchi N
    Cancer Sci; 2013 Aug; 104(8):1127-34. PubMed ID: 23679813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer.
    Ahmed MA; Aleskandarany MA; Rakha EA; Moustafa RZ; Benhasouna A; Nolan C; Green AR; Ilyas M; Ellis IO
    Breast Cancer Res Treat; 2012 Jun; 133(3):979-95. PubMed ID: 22119938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
    Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
    Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
    World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
    Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM
    Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G; Wu X; Zhou L; Yu L; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
    Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
    World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion.
    Fujikuni N; Yamamoto H; Tanabe K; Naito Y; Sakamoto N; Tanaka Y; Yanagihara K; Oue N; Yasui W; Ohdan H
    Cancer Sci; 2014 Nov; 105(11):1411-20. PubMed ID: 25174257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.